Navigation Links
Korean Food and Drug Administration Approval for ActiPatch Achieved

FREDERICK, Md., Oct. 16 /PRNewswire-FirstCall/ -- BioElectronics Corporation, (Pink Sheets: BIEL), announced today that the by the Korean Food and Drug Administration has cleared ActiPatch for sale in Korea.

"We have been working closely with our distributor, YoungKwangSa Co., Ltd., to achieve the approval of the Korean F.D.A. Having worked so diligently to obtain the approvals, we are confident that YoungKwangSa is now poised to successfully launch ActiPatch in the Korean market. We expect to ship the initial stock order within the next 15 days," said Andrew Whelan, President of BioElectronics Corporation.

Marshal Nam of YoungKwangSa said "We are pleased to have achieved the clearance from the Korean FDA to begin importing the ActiPatch device. It was a long process and we worked cooperatively with BioElectronics Corporation to obtain the necessary approvals. We are excited to represent ActiPatch in Korea and expect to have a strong business relationship with BioElectronics Corporation for many years."

About YoungKwangSa Co., Ltd.:

Founded in 1971, YoungKwangSa has provided medical professionals in Korea with the most state-of-the art medical devices available. To learn more about YoungKwangSa please visit

About BioElectronics:

BioElectronics Corporation is the maker of ActiPatch. ActiPatch is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.

For more information visit

Safe Harbor Statement:

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.

SOURCE BioElectronics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Brady Corp. acquires Korean counterpart
2. Third Wave seeks approval of Cystic Fibrosis test
3. Kyron wins FDA approval for brain imaging technology
4. SGI receives court approval for bankruptcy motions
5. FDA programs encourage and expedite drug development and approval
6. UW-Stevens Point Professor Receives Patent Approval For New Technology
7. High-Efficiency Transfections Achieved with New Low-Toxicity Reagent
8. 140-Fold Increase of Protein Achieved in Pichia Fermentation
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts ... they believe could be a new and helpful biomarker for malignant pleural mesothelioma. ... here to read it now. , Biomarkers are components in the blood, ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
(Date:3/23/2016)... 23, 2016 ... Gesichts- und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler ... mit SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie ... die Möglichkeit angeboten, im Rahmen mobiler Apps ...
(Date:3/21/2016)... WAKEFIELD, Massachusetts , March 22, 2016 ... and facial recognition with passcodes for superior security ... MESG ), a leading provider of secure digital communications ... pilot their biometric technology and offer enterprise customers, particularly ... provide secure facial recognition and voice authentication within a ...
Breaking Biology News(10 mins):